Financial Snapshot
This section of the Fusion Pharmaceuticals InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing.
Please note: All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes. Fusion Pharmaceuticals assumes no responsibility for the accuracy of this data and provides it for informational purposes only.
NASDAQFUSN
| Beta | 0.04 |
|---|---|
| Shares Outstanding | 42.4M |
| Average Volume (10 days) | 67.9K |
| Qtrly Dividend (Ann. Yield) | -- (--) |
Analyst Views
| Current Mean Recommendation | Strong Buy |
|---|
| Strong Buy | 4 | |
|---|---|---|
| Buy | 1 | |
| Hold | 0 | |
| Underperform | 0 | |
| Sell | 0 |
Recent Insider Transactions
Heather Preston Director | 8,823 Buy Jun 30, 2020 |
|---|---|
Chau Q. Khuong Director | 705,900 Buy Jun 30, 2020 |
Chau Q. Khuong Director | 192,100 Buy Jun 30, 2020 |
Johan Christenson Director | 240,000 Buy Jun 30, 2020 |
Heather Preston | 8,823 Buy Jun 30, 2020 |
Recent SEC Filings
| Company Events | Apr 2, 2021 |
|---|---|
| Company Events | Apr 2, 2021 |
| Insider Buy/Sell | Apr 1, 2021 |
| New Insider | Apr 1, 2021 |
| SEC STAFF LETTER | Mar 29, 2021 |
NEVER MISS AN UPDATE
